PAR 2.22% 22.0¢ paradigm biopharmaceuticals limited..

Paradigm Competition, page-3

  1. 4,433 Posts.
    lightbulb Created with Sketch. 6996
    It's a pass from me...
    Part immunosuppressant...
    Intra articular and a couple of warnings:


    "Serious and sometimes fatal infections may occur during treatment with canakinumab. Call your doctor right away if you have signs of infection such as: fever, chills, sweating, tiredness, cough, shortness of breath, skin sores, warm or painful areas on your body, diarrhea, stomach pain, or weight loss".1



    "Canakinumab can weaken your immune system. Your blood may need to be tested often"
    . 1



    (My emphasis added below)


    "Innate immunity drives atherogenesis and cardiovascular risk, but also participates in host defenses against pathogens. The Canakinumab Anti-Inflammatory Thrombosis Outcomes Trial (CANTOS) showed that treatment with the anti-interleukin-1β antibody canakinumab improved cardiovascular outcomes, but associated with a small increase in fatal infections".2




    Not saying it doesn't have a place (?)..but I know what I'd wait for and which drug I'd be trying out first...





    DYOR



    REF
    1) https://www.drugs.com/mtm/canakinumab.html#:~:text=Warnings-,Serious%20and%20sometimes%20fatal%20infections%20may%20occur%20during%20treatment%20with,stomach%20pain%2C%20or%20weight%20loss.
    2) https://academic.oup.com/eurheartj/article/39/suppl_1/ehy564.358/5080115
    Last edited by Mozzarc: 18/11/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.0¢
Change
-0.005(2.22%)
Mkt cap ! $76.98M
Open High Low Value Volume
22.0¢ 22.0¢ 22.0¢ $6.62K 30.08K

Buyers (Bids)

No. Vol. Price($)
5 123767 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 48479 2
View Market Depth
Last trade - 10.06am 12/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.